Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A A new risk of bias checklist applicable to randomized trials, observational studies and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events. PMID: 28487158 Journal: JOURNAL OF CLINICAL EPIDEMIOLOGY Year: 2017 Reference: J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6. Impact factor: 4.978 Publication type: Paper in international publication Authors: Faillie, Jean-Luc, Ferrer, Pili, Gouverneur, Amandine, Driot, Damien, Berkemeyer, Shoma, Vidal, Xavier, Martinez-Zapata, Maria Jose, Huerta, Consuelo, Rottenkolber, Marietta, Schmiedl, Sven et al. DOI: 10.1016/j.jclinepi.2017.04.023 A new risk of bias checklist applicable to randomized trials, observational studies and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events. PMID: 28487158 Journal: JOURNAL OF CLINICAL EPIDEMIOLOGY Year: 2017 Reference: J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6. Impact factor: Publication type: Paper in international publication Authors: Ballarin, Elena; Berkemeyer, Shoma; Castells, Xavier; Driot, Damien; Faillie, Jean-Luc; Ferrer, Pili; Gouverneur, Amandine; Huerta, Consuelo; Ibanez, Luisa; Martinez-Zapata, Maria Jose et al. DOI: 10.1016/j.jclinepi.2017.04.023 A new two-step algorithm for the treatment of COPD. PMID: 28179443 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2017 Reference: Eur Respir J. 2017 Feb 8;49(2). pii: 1602200. doi: 10.1183/13993003.02200-2016. Print 2017 Feb. Impact factor: 10.569 Publication type: Letter or abstract Authors: Miravitlles, Marc, Anzueto, Antonio et al. DOI: 10.1183/13993003.02200-2016 A new two-step algorithm for the treatment of COPD. PMID: 28179443 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2017 Reference: Eur Respir J. 2017 Feb 8;49(2). pii: 1602200. doi: 10.1183/13993003.02200-2016. Print 2017 Feb. Impact factor: Publication type: Letter or abstract Authors: Anzueto, Antonio; Miravitlles, Marc et al. DOI: 10.1183/13993003.02200-2016 A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats. PMID: 28084470 Journal: Scientific Reports Year: 2017 Reference: Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461. Impact factor: 4.259 Publication type: Paper in international publication Authors: Rodriguez, Sarai, Raurell, Imma, Torres-Arauz, Manuel, Garcia-Lezana, Teresa, Genesca, Joan, Martell, Maria et al. DOI: 10.1038/srep40461 A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats. PMID: 28084470 Journal: Scientific Reports Year: 2017 Reference: Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461. Impact factor: Publication type: Paper in international publication Authors: Garcia-Lezana, Teresa; Genesca, Joan; Martell, Maria; Raurell, Imma; Rodriguez, Sarai; Torres-Arauz, Manuel et al. DOI: 10.1038/srep40461 A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. PMID: 28698276 Journal: mBio Year: 2017 Reference: MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17. Impact factor: 6.956 Publication type: Paper in international publication Authors: Buzon, Maria J, Crespo, Manuel, Falco, Vicenc, Grau-Exposito, Judith, Miguel, Lucia, Navarro, Jordi, Curran, Adria, Burgos, Joaquin, Ocana, Imma, Ribera, Esteban et al. DOI: 10.1128/mBio.00876-17 A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. PMID: 28698276 Journal: mBio Year: 2017 Reference: MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17. Impact factor: Publication type: Paper in international publication Authors: Badia, Rosa; Burgos, Joaquin; Buzon, Maria J; Castellvi, Josep; Crespo, Manuel; Curran, Adria; Falco, Vicenc; Grau-Exposito, Judith; Miguel, Lucia; Navarro, Jordi et al. DOI: 10.1128/mBio.00876-17 A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts. PMID: 28546581 Journal: LEUKEMIA Year: 2017 Reference: Leukemia. 2017 Dec;31(12):2799-2806. doi: 10.1038/leu.2017.159. Epub 2017 May 26. Impact factor: 11.702 Publication type: Paper in international publication Authors: Illes, A, Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Stauder, R, Yee, K et al. DOI: 10.1038/leu.2017.159 A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts. PMID: 28546581 Journal: LEUKEMIA Year: 2017 Reference: Leukemia. 2017 Dec;31(12):2799-2806. doi: 10.1038/leu.2017.159. Epub 2017 May 26. Impact factor: Publication type: Paper in international publication Authors: Acharyya, S; Borbenyi, Z; Breccia, M; Cavenagh, J D; DeAngelo, D J; Egyed, M; Fenaux, P; Garcia-Manero, G; Gazi, L; Graux, C et al. DOI: 10.1038/leu.2017.159 A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. PMID: 28899363 Journal: BMC CANCER Year: 2017 Reference: BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6. Impact factor: 3.288 Publication type: Paper in international publication Authors: Reynolds, Kerry Lynn, Bedard, Philippe L, Lee, Se-Hoon, Lin, Chia-Chi, Tabernero, Josep, Alsina, Maria, Cohen, Ezra, Baselga, Jose, Blumenschein, George Jr, Graham, Donna M et al. DOI: 10.1186/s12885-017-3641-6 A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. PMID: 28899363 Journal: BMC CANCER Year: 2017 Reference: BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6. Impact factor: Publication type: Paper in international publication Authors: Alsina, Maria; Bang, Yung-Jue; Baselga, Jose; Bedard, Philippe L; Blumenschein, George Jr; Cohen, Ezra; Fernandez, Rose; Garrido-Laguna, Ignacio; Graham, Donna M; Juric, Dejan et al. DOI: 10.1186/s12885-017-3641-6 A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. PMID: 28592615 Journal: ONCOLOGIST Year: 2017 Reference: Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7. Impact factor: 4.962 Publication type: Paper in international publication Authors: Lieu, Christopher H, Hidalgo, Manuel, Berlin, Jordan D, Ko, Andrew H, Cervantes, Andres, LoRusso, Patricia, Gerber, David E, Eder, J Paul, Eckhardt, S Gail, Kapp, Amy V et al. DOI: 10.1634/theoncologist.2017-0175 A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. PMID: 28592615 Journal: ONCOLOGIST Year: 2017 Reference: Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7. Impact factor: Publication type: Paper in international publication Authors: Berlin, Jordan D; Cervantes, Andres; Eckhardt, S Gail; Eder, J Paul; Gerber, David E; Hidalgo, Manuel; Kapp, Amy V; Ko, Andrew H; Lieu, Christopher H; LoRusso, Patricia et al. DOI: 10.1634/theoncologist.2017-0175 A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C. PMID: 28527133 Journal: INVESTIGATIONAL NEW DRUGS Year: 2017 Reference: Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19. Impact factor: 3.484 Publication type: Clinical guide Authors: Almhanna, Khaldoun, Wright, David, Mercade, Teresa Macarulla, Van Laethem, Jean-Luc, Gracian, Antonio Cubillo, Guillen-Ponce, Carmen, Faris, Jason, Lopez, Carolina Muriel, Hubner, Richard A, Bendell, Johanna et al. DOI: 10.1007/s10637-017-0473-9 A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C. PMID: 28527133 Journal: INVESTIGATIONAL NEW DRUGS Year: 2017 Reference: Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19. Impact factor: Publication type: Clinical guide Authors: Almhanna, Khaldoun; Bendell, Johanna; Bols, Alain; Danaee, Hadi; Enzinger, Peter; Faris, Jason; Fasanmade, Adedigbo; Feliu, Jaime; Gracian, Antonio Cubillo; Guillen-Ponce, Carmen et al. DOI: 10.1007/s10637-017-0473-9 A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. PMID: 28911091 Journal: ANNALS OF ONCOLOGY Year: 2017 Reference: Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. Impact factor: 11.855 Publication type: Paper in international publication Authors: Esko, V, Abdalla, K, Verma, U, Benedetti, F, Aoyama, T, Mizuguchi, H, Makris, L, Rosati, G, Elme, A, Feliu, J et al. DOI: 10.1093/annonc/mdx275 A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. PMID: 28911091 Journal: ANNALS OF ONCOLOGY Year: 2017 Reference: Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. Impact factor: Publication type: Paper in international publication Authors: Abdalla, K; Abramov, M; Ajani, J A; Alsina, M; Aoyama, T; Benedetti, F; Bondarenko, I; Elme, A; Esko, V; Feliu, J et al. DOI: 10.1093/annonc/mdx275 A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time. PMID: 28216380 Journal: PREVENTIVE MEDICINE Year: 2017 Reference: Prev Med. 2017 Jun;99:111-117. doi: 10.1016/j.ypmed.2017.02.010. Epub 2017 Feb 16. Impact factor: 3.434 Publication type: Paper in international publication Authors: Campins, Magda, Vilca, Luz Maria, Verma, Aman, Buckeridge, David et al. DOI: 10.1016/j.ypmed.2017.02.010 A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time. PMID: 28216380 Journal: PREVENTIVE MEDICINE Year: 2017 Reference: Prev Med. 2017 Jun;99:111-117. doi: 10.1016/j.ypmed.2017.02.010. Epub 2017 Feb 16. Impact factor: Publication type: Paper in international publication Authors: Buckeridge, David; Campins, Magda; Verma, Aman; Vilca, Luz Maria et al. DOI: 10.1016/j.ypmed.2017.02.010 A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. PMID: 29183382 Journal: RESPIRATORY RESEARCH Year: 2017 Reference: Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y. Impact factor: 3.841 Publication type: Review in national publication Authors: Miravitlles, Marc, Cosio, Borja G, Arnedillo, Aurelio, Calle, Myriam, Alcazar-Navarrete, Bernardino, Gonzalez, Cruz, Esteban, Cristobal, Trigueros, Juan Antonio, Rodriguez Gonzalez-Moro, Jose Miguel, Quintano Jimenez, Jose Antonio et al. DOI: 10.1186/s12931-017-0682-y A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. PMID: 29183382 Journal: RESPIRATORY RESEARCH Year: 2017 Reference: Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y. Impact factor: Publication type: Review in national publication Authors: Alcazar-Navarrete, Bernardino; Arnedillo, Aurelio; Baloira, Adolfo; Calle, Myriam; Cosio, Borja G; Esteban, Cristobal; Gonzalez, Cruz; Miravitlles, Marc; Quintano Jimenez, Jose Antonio; Rodriguez Gonzalez-Moro, Jose Miguel et al. DOI: 10.1186/s12931-017-0682-y A Prospective International Aspergillus terreus Survey: An EFISG, ISHAM and ECMM Joint Study. PMID: 28412383 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2017 Reference: Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13. Impact factor: 5.292 Publication type: Paper in international publication Authors: Zoran, Tamara, Lackner, Michaela, Aigner, Maria, Sanchez-Reus, Ferran, Rezusta, Antonio, Chowdhary, Anuradha, Taj-Aldeen, Saad Jaber, Arendrup, Maiken C, Oliveri, Salvatore, Kontoyiannis, Dimitrios P et al. DOI: 10.1016/j.cmi.2017.04.012 A Prospective International Aspergillus terreus Survey: An EFISG, ISHAM and ECMM Joint Study. PMID: 28412383 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2017 Reference: Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13. Impact factor: Publication type: Paper in international publication Authors: Aigner, Maria; Alastruey-Izquierdo, Ana; Arendrup, Maiken C; Arikan-Akdagli, Sevtap; Arsic-Arsenijevic, Valentina; Badali, Hamid; Buzina, Walter; Chakrabarti, Arunaloke; Chowdhary, Anuradha; Colombo, Arnaldo L et al. DOI: 10.1016/j.cmi.2017.04.012 Pagination First page « First Previous page ‹ Previous … Page 945 Page 946 Page 947 Page 948 Current page 949 Page 950 Page 951 Page 952 Page 953 … Next page Next › Last page Last »
